Cargando…

Safety and Efficacy of Amiodarone in a Patient With COVID-19

There is an urgent need for effective treatments for coronavirus disease-2019 (COVID-19). Amiodarone, like hydroxychloroquine, exerts antiviral actions by interfering with endocytosis and viral replication. Here, to our knowledge, we report the first case of a patient affected by respiratory failure...

Descripción completa

Detalles Bibliográficos
Autores principales: Castaldo, Nadia, Aimo, Alberto, Castiglione, Vincenzo, Padalino, Cristiano, Emdin, Michele, Tascini, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259916/
https://www.ncbi.nlm.nih.gov/pubmed/32835273
http://dx.doi.org/10.1016/j.jaccas.2020.04.053
_version_ 1783540227179020288
author Castaldo, Nadia
Aimo, Alberto
Castiglione, Vincenzo
Padalino, Cristiano
Emdin, Michele
Tascini, Carlo
author_facet Castaldo, Nadia
Aimo, Alberto
Castiglione, Vincenzo
Padalino, Cristiano
Emdin, Michele
Tascini, Carlo
author_sort Castaldo, Nadia
collection PubMed
description There is an urgent need for effective treatments for coronavirus disease-2019 (COVID-19). Amiodarone, like hydroxychloroquine, exerts antiviral actions by interfering with endocytosis and viral replication. Here, to our knowledge, we report the first case of a patient affected by respiratory failure related to COVID-19 who recovered after only supportive measures and a short amiodarone course. (Level of Difficulty: Beginner.)
format Online
Article
Text
id pubmed-7259916
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-72599162020-06-01 Safety and Efficacy of Amiodarone in a Patient With COVID-19 Castaldo, Nadia Aimo, Alberto Castiglione, Vincenzo Padalino, Cristiano Emdin, Michele Tascini, Carlo JACC Case Rep First Reported There is an urgent need for effective treatments for coronavirus disease-2019 (COVID-19). Amiodarone, like hydroxychloroquine, exerts antiviral actions by interfering with endocytosis and viral replication. Here, to our knowledge, we report the first case of a patient affected by respiratory failure related to COVID-19 who recovered after only supportive measures and a short amiodarone course. (Level of Difficulty: Beginner.) Elsevier 2020-05-29 /pmc/articles/PMC7259916/ /pubmed/32835273 http://dx.doi.org/10.1016/j.jaccas.2020.04.053 Text en © 2020 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle First Reported
Castaldo, Nadia
Aimo, Alberto
Castiglione, Vincenzo
Padalino, Cristiano
Emdin, Michele
Tascini, Carlo
Safety and Efficacy of Amiodarone in a Patient With COVID-19
title Safety and Efficacy of Amiodarone in a Patient With COVID-19
title_full Safety and Efficacy of Amiodarone in a Patient With COVID-19
title_fullStr Safety and Efficacy of Amiodarone in a Patient With COVID-19
title_full_unstemmed Safety and Efficacy of Amiodarone in a Patient With COVID-19
title_short Safety and Efficacy of Amiodarone in a Patient With COVID-19
title_sort safety and efficacy of amiodarone in a patient with covid-19
topic First Reported
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259916/
https://www.ncbi.nlm.nih.gov/pubmed/32835273
http://dx.doi.org/10.1016/j.jaccas.2020.04.053
work_keys_str_mv AT castaldonadia safetyandefficacyofamiodaroneinapatientwithcovid19
AT aimoalberto safetyandefficacyofamiodaroneinapatientwithcovid19
AT castiglionevincenzo safetyandefficacyofamiodaroneinapatientwithcovid19
AT padalinocristiano safetyandefficacyofamiodaroneinapatientwithcovid19
AT emdinmichele safetyandefficacyofamiodaroneinapatientwithcovid19
AT tascinicarlo safetyandefficacyofamiodaroneinapatientwithcovid19